CAR-GPRC5D

· Nanjing IASO Biotechnology Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CAR-GPRC5D, covering 2025-05-20 to 2025-06-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study of CAR-GPRC5D in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia [Phase 1]